Trends in Helicobacter pylori eradication rates by first-line triple therapy and related factors in eradication therapy
Sung Eun Kim, Moo In Park, Seun Ja Park, Won Moon, Youn Jung Choi, Ji Hyun Cheon, Hye Jung Kwon, Ki Hwan Ku, Chang Hun Yoo, Jae Hyun Kim, Gyu Won Lee, Sung Eun Song
Korean J Intern Med. 2015;30(6):801-807.   Published online 2015 Oct 30     DOI: https://doi.org/10.3904/kjim.2015.30.6.801
Citations to this article as recorded by Crossref logo
Gastric juice‐based PCR assay: An alternative testing method to aid in the management of previously treated Helicobacter pylori infection
Meng‐Shu Hsieh, Chung‐Jung Liu, Wen‐Hung Hsu, Chia‐Jung Li, Pei‐Yun Tsai, Huang‐Ming Hu, Hsiang‐Yao Shih, Chien‐Yu Lu, Fang‐Jung Yu, Fu‐Chen Kuo, Deng‐Chyang Wu, Chao‐Hung Kuo
Helicobacter.2019; 24(2): e12568.     CrossRef
Effect of 7-day Bismuth Quadruple Therapy versus 14-day Moxifloxacin Triple Therapy for Second-line Helicobacter pylori Eradication Therapy
Sung Eun Kim, Ji Hun Roh, Moo In Park, Seun Ja Park, Won Moon, Jae Hyun Kim, Kyoungwon Jung, Jae Joon Heo
The Korean Journal of Gastroenterology.2019; 73(1): 26.     CrossRef
Can Aminoglycosides Be Used as a New Treatment for Helicobacter pylori? In vitro Activity of Recently Isolated Helicobacter pylori
Kyoung Hwa Lee, Soon Young Park, Su Jin Jeong, Da Hyun Jung, Jie-Hyun Kim, Seok Hoon Jeong, Il-Mo Kang, Young Goo Song
Infection & Chemotherapy.2019; 51(1): 10.     CrossRef
Predictors of triple therapy treatment failure among H. pylori infected patients attending at a tertiary hospital in Northwest Tanzania: a prospective study
Hyasinta Jaka, Andreas Mueller, Christa Kasang, Stephen E. Mshana
BMC Infectious Diseases.2019;[Epub]     CrossRef
Erradicación de la infección por Helicobacter pylori con una nueva terapia cuádruple basada en bismuto en la práctica clínica
Elena Pérez-Arellano, María Isabel Rodriguez-Garcia, Ana Belen Galera Rodenas, Emilio de la Morena-Madrigal
Gastroenterología y Hepatología.2018; 41(3): 145.     CrossRef
Inappropriate treatment in Helicobacter pylori eradication failure: a retrospective study
Huiyi Li, Xiao Liang, Qi Chen, Wei Zhang, Hong Lu
Scandinavian Journal of Gastroenterology.2018; 53(2): 130.     CrossRef
Sex differences in urea breath test results for the diagnosis of Helicobacter pylori infection: a large cross-sectional study
Ido Eisdorfer, Varda Shalev, Sophy Goren, Gabriel Chodick, Khitam Muhsen
Biology of Sex Differences.2018;[Epub]     CrossRef
Eradication of Helicobacter pylori infection with a new bismuth-based quadruple therapy in clinical practice
Elena Pérez-Arellano, María Isabel Rodriguez-Garcia, Ana Belen Galera Rodenas, Emilio de la Morena-Madrigal
Gastroenterología y Hepatología (English Edition).2018; 41(3): 145.     CrossRef
IVTH BRAZILIAN CONSENSUS CONFERENCE ON HELICOBACTER PYLORI INFECTION
Luiz Gonzaga Vaz COELHO, James Ramalho MARINHO, Robert GENTA, Laercio Tenório RIBEIRO, Maria do Carmo Friche PASSOS, Schlioma ZATERKA, Paulo Pimentel ASSUMPÇÃO, Alfredo José A BARBOSA, Ricardo BARBUTI, Lucia Libanês BRAGA, Helenice BREYER, Aloisio CARVALH
Arquivos de Gastroenterologia.2018; 55(2): 97.     CrossRef
Clinical relevance of point mutations in the 23S rRNA gene in Helicobacter pylori eradication
Chang-Geun Park, Seohyeon Kim, Eun-Ju Lee, Hyo-Sung Jeon, Seungwoo Han
Medicine.2018; 97(33): e11835.     CrossRef
Peptide Nucleic Acid Probe-Based Analysis as a New Detection Method for Clarithromycin Resistance in Helicobacter pylori
Da Hyun Jung, Jie-Hyun Kim, Su Jin Jeong, Soon Young Park, Il-Mo Kang, Kyoung Hwa Lee, Young Goo Song
Gut and Liver.2018; 12(6): 641.     CrossRef
Triple therapy versus sequential therapy for the first-line Helicobacter pylori eradication
Ji Young Chang, Ki-Nam Shim, Chung Hyun Tae, Ko Eun Lee, Jihyun Lee, Kang Hoon Lee, Chang Mo Moon, Seong-Eun Kim, Hye-Kyung Jung, Sung-Ae Jung
BMC Gastroenterology.2017;[Epub]     CrossRef
Levofloxacin or Clarithromycin-based quadruple regimens: what is the best alternative as first-line treatment for Helicobacter pylori eradication in a country with high resistance rates for both antibiotics?
Diogo Branquinho, Nuno Almeida, Carlos Gregório, José Eduardo Pina Cabral, Adriano Casela, Maria Manuel Donato, Luís Tomé
BMC Gastroenterology.2017;[Epub]     CrossRef
Helicobacter pylori Eradication Rate in Patients with Diabetes
Jiyeon Yoo, Yeong Ji Yu, Gumin Cho, Hongkwon Oh, Seung Hyun Oh, Tae Ho Kim, Jung Hwan Oh
The Korean Journal of Helicobacter and Upper Gastrointestinal Research.2017; 17(2): 83.     CrossRef
Efficacy and safety of rifaximin associated with standard triple therapy (omeprazole, clarithromycin and amoxicillin) for H. pylori eradication: A phase IV pilot clinical trial
Mercedes Ramas, Maria G. Donday, Adrian G. McNicholl, Javier P. Gisbert
Gastroenterología y Hepatología.2017; 40(10): 658.     CrossRef
The Efficacy of Moxifloxacin-containing Triple Therapy after Hybrid Therapy Failure in Helicobacter pylori Eradication
Soohoon Kwon, Dong Ho Lee, Jae Bin Kang, Nayoung Kim, Young Soo Park, Cheol Min Shin, Hyuk Yoon, Yoon Jin Choi
The Korean Journal of Gastroenterology.2017; 70(2): 72.     CrossRef
Second-line bismuth-containing quadruple therapy for Helicobacter pylori eradication and impact of diabetes
Sung Eun Kim, Moo In Park, Seun Ja Park, Won Moon, Jae Hyun Kim, Kyoungwon Jung, Hae Koo Kim, Young Dal Lee
World Journal of Gastroenterology.2017; 23(6): 1059.     CrossRef
Efficacy and safety of rifaximin associated with standard triple therapy (omeprazole, clarithromycin and amoxicillin) for H. pylori eradication: A phase IV pilot clinical trial
Mercedes Ramas, Maria G. Donday, Adrian G. McNicholl, Javier P. Gisbert
Gastroenterología y Hepatología (English Edition).2017; 40(10): 658.     CrossRef
A high-throughput multiplex genetic detection system for Helicobacter pylori identification, virulence and resistance analysis
Binjie Hu, Fuju Zhao, Shiwen Wang, Michal A Olszewski, Haipeng Bian, Yong Wu, Mimi Kong, Lingli Xu, Yingxin Miao, Yi Fang, Changqing Yang, Hu Zhao, Yanmei Zhang
Future Microbiology.2016; 11(10): 1261.     CrossRef
The Influence of Iron Deficiency onHelicobacter pyloriEradication
Sung Eun Kim, Moo In Park, Seun Ja Park, Won Moon, Jae Hyun Kim, Kyoungwon Jung, Kwang Il Seo, Seong Kyeong Lim, Jin Kyu Jung, Hyeon Jin Kim, Go Eun Yeo, Sung Chan Jeon, Duk Song Cho, You Jin Han
The Korean Journal of Helicobacter and Upper Gastrointestinal Research.2016; 16(2): 82.     CrossRef
First-line Helicobacter pylori eradication among patients with chronic liver diseases in Taiwan
Cheng-En Tsai, Chih-Ming Liang, Chen-Hsiang Lee, Yuan-Hung Kuo, Keng-Liang Wu, Yi-Chun Chiu, Wei-Chen Tai, Seng-Kee Chuah
The Kaohsiung Journal of Medical Sciences.2016; 32(8): 397.     CrossRef